Farmaks SRL
Farmaks reported total assets of €2.94m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Aug 2026).
The score of Farmaks shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +14 % Total assets +27 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmaks's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Aug 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 09 Aug 2022
Farmaks's financial analysis
- Solvency64.3%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmaks
Farmaks's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0471.595.984
- VAT number
- BE0471595984
- Peppol
- Registered · 0208:0471595984 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Apr 2000
- Registered office
- 8300 Knokke-Heist
- Latest accounts
- 2025 · filed on 29 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Farmaks (SRL) has been based in Knokke-Heist since 2000, active in: activities of holding companies. For 2025, it reports a net profit of 375,394 € and equity of €1.89m; its revenue is not published. Its solvency stands at 64.3%, above the median of its sector (55.6%).
Companies similar to Farmaks
Companies in the same business, of comparable size and area, outside its group.
- Dybas Activities of holding companies Retie · balance sheet €2.94m
- Future Management Activities of holding companies Woluwe-Saint-Lambert · balance sheet €2.93m
- HET Eindeke Activities of holding companies Heist-op-den-Berg · balance sheet €2.93m
- D.L.C. Holding Activities of holding companies Grobbendonk · balance sheet €2.93m
- Holding T.F. Activities of holding companies Beveren-Kruibeke-Zwijndrecht · balance sheet €2.93m
- Stinaco Activities of holding companies Houthulst · balance sheet €2.93m
- Just-Venture Activities of holding companies Oudenaarde · balance sheet €2.93m
- Notariële Participatievennootschap Julauva Activities of holding companies Ronse · balance sheet €2.93m
Frequently asked questions about Farmaks
What is the revenue of Farmaks?
Farmaks files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmaks?
In Belgium, the VAT number is the company number prefixed with BE: BE0471595984 for Farmaks, if the company is VAT-registered. Its company number (CBE) is 0471.595.984.
Where is the registered office of Farmaks?
According to the CBE register, the registered office of Farmaks is in 8300 Knokke-Heist.
What is the equity of Farmaks?
At the close of the 2025 financial year, the equity of Farmaks amounts to 1,888,999 €, a solvency of 64.3% of total assets.
Who manages Farmaks?
The register lists 2 active mandates at Farmaks. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmaks
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →